Le Lézard
Classified in: Health
Subject: FDA

FDA Clears Innovative Treatment for Obstructive Sleep Disorders


HOUSTON, Feb. 27, 2018 /PRNewswire/ -- The Center for Craniofacial & Dental Sleep Medicine (CFDSM), a Houston-based company specializing in dental sleep medicine and sleep apnea treatment, announced that it has received FDA clearance on its innovative new treatment for obstructive sleep apnea (OSA) and snoring, The Meridian PM oral appliance.

During sleep, the tongue, muscles of the soft palate and the uvula relax, obstructing the airway leading to sleep disorder breathing. Sleep disorder breathing affects more than 42 million people annually, nationwide. In Houston alone, about 1.2 million people suffer from this disorder each year.

Effects and Traditional Treatments of OSA

OSA is a serious disease that can cause both daytime symptoms like fatigue, poor memory, concentration and performance, and nighttime symptoms like snoring, insomnia, and frequent awakening. Left untreated, OSA can result in a number of health problems, including high blood pressure, stroke, diabetes, depression and heart attacks.

Traditional treatments for obstructive sleep apnea offer limited results. CPAP (continuous positive airway pressure) is a common treatment, featuring a mask and a pressurized breathing machine. The CPAP is not monitored, cumbersome, and users often become non-compliant. Many patients stop using the CPAP altogether.

Another common treatment for OSA is the mandibular advancement device (MAD). This is a customized oral appliance created and modified by a dentist.  MADs hold the lower jaw in a forward position keeping the tongue away from the back of the throat opening the airway.  Over time, this jaw position can lead to bite changes and jaw joint pain.

Finally, surgery is often the last resort for severe cases of obstructive sleep apnea.

The Meridian PM represents a revolutionary development in oral appliance therapies.

By holding the lower jaw in a more comfortable position, the Meridian PM eliminates the potential jaw pain and changes in the patient's bite often experienced with traditional oral appliance therapy. It effectively treats snoring, OSA and associated breathing symptoms by stabilizing the lower jaw and training the tongue to stay forward, maintaining a clear upper airway during sleep. The natural result is a decrease in the frequency and duration of apneic and hypopnea events, including snoring. The appliance supports oxygen exchange during sleep, improving health and social consequences associated with OSA and snoring.

"We tested the Meridian PM against traditional therapies and confirmed that it provides a better, more effective treatment option for OSA," states Cress. "This translates to better access to treatment for people suffering from this potentially dangerous disorder."

For more information on the Meridian PM appliance, visit meridianpm.us.

Dr. Samuel E. Cress
Founder
Center for Craniofacial & Dental Sleep Medicine
(281) 565-4100
[email protected]

This release was issued through WebWire(R). For more information, visit http://www.webwire.com.

SOURCE Center for Craniofacial & Dental Sleep Medicine


These press releases may also interest you

at 11:00
The Physician-Patient Alliance for Health & Safety (PPAHS) is pleased to announce that Graceland Rehabilitation and Nursing Center in Memphis, TN, is the first nursing facility in West Tennessee to...

at 11:00
Thinx, the #1 selling reusable period underwear brand in retail, has launched styles featuring its new LeakSafetm Barrier technology. Available across all products ? Thinx, Thinx Teens®, and Thinx for Alltm ? the innovation offers all-day absorbency...

at 11:00
AIxMed, innovators and providers of an AI-powered computational platform for cytology applications, and CorePlus a leader in precision pathology have entered into an agreement to conduct a pilot study applying the AIxMed's AI algorithm to test a...

at 10:50
Karoo Health, the only operational provider of cardiac value-based care (VBC) enablement with published results, today launched Kohere.ai, its proprietary cloud-based platform that augments the company's proven model of care (MoC) for cardiovascular...

at 10:49
The Multiple Sclerosis Association of America (MSAA) is excited to invite members of the MS community to our 10th Improving Lives Benefit on Wednesday, May 15, 2024, at 6:30 pm ET, at the Barnes Foundation in Philadelphia, PA. This event will also be...

at 10:48
Glytec, whose industry leading SaaS platform empowers collaborative diabetes management and insulin dosing from the hospital to the home, announces a major step forward in its advocacy and partnership efforts to drive excellence in diabetes care and...



News published on and distributed by: